Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article Report
  • Published:

Reply to “Epilepsies in children—the power of making a syndrome diagnosis”

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Kassaï B et al. (2007) Severe myoclonic epilepsy in infancy: a systematic review and a meta-analysis of individual patient data. Epilepsia 49: 343–348

    Article  Google Scholar 

  2. Chiron C (2008) et al. (2000) Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group. Lancet 356: 1638–1642

    Article  Google Scholar 

  3. Striano P et al. (2007) An open-label trial of levetiracetam in severe myoclonic epilepsy of infancy. Neurology 69: 250–254

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pasquale Striano.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Striano, P., Striano, S. & Zara, F. Reply to “Epilepsies in children—the power of making a syndrome diagnosis”. Nat Rev Neurol 4, E3 (2008). https://doi.org/10.1038/ncpneuro0831

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/ncpneuro0831

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing